Time interval for booster vaccination following reexposure to rabies in previously vaccinated subjects

1. Goswami A. Rabies re-exposure realities. APCRI Journal. 2007; 7:19-23.Search in Google Scholar

2. World Health Organisation. Rabies vaccines: WHO position paper, Weekly Epidemiological Record. 2010; 85:309-20.Search in Google Scholar

3. Charanasri U, Kingnate D, Meesomboon V, Samuthananon P, Chaeychomsri W. Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine. J Med Assoc Thai. 1992; 75:639-42.Search in Google Scholar

4. Sudarshan MK, Bhardwaj S, Mehta JM, Parasuramalu BG, Mahendra BJ, Gangaboraiah. Clinical evaluation of safety and efficacy of PCEC rabies vaccine (Kaketsuken) in post- exposure treatment. Indian J. Maternal and Child Health. 1996; 7:49-52.Search in Google Scholar

5. Warell MJ, Warrell DA, Suntharasamai P, Nicholson KG, Chanthavanich P, Viravan C et al. Multisite intradermal rabies vaccination: Improoved economical regimens. Lancet. 1984; 1: 874-6.10.1016/S0140-6736(84)91340-0Open DOISearch in Google Scholar

6. Warell MJ, Nicholson KG, Warrell DA, Suntharasamai P, Chanthavanich P, Viravan C et al. Economical multiple-site intradermal immunization with human diploid cell strain vaccine is effective for post-exposure rabies prophylaxis. The Lancet. 1985; 1:1059-62.10.1016/S0140-6736(85)92367-0Open DOISearch in Google Scholar

7. Warell MJ, Warrell DA, Suntharasamai P, Viravan C, Sinhaseni A, Udomsakdi D et al. An economical regimen of human diploid cell strain anti-rabies vaccine for post- exposure prophylaxis. The Lancet. 1983: 301-4.10.1016/S0140-6736(83)90288-XOpen DOISearch in Google Scholar

8. Suntharasamai P, Chaiprasithikul P, Wasi C, Supanaranond W, Auewarakul P, Chanthavanich P et al. A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis. Vaccine. 1994; 12:508-12.10.1016/0264-410X(94)90308-5Open DOISearch in Google Scholar

9. Beran J, Honegr K, Banzhoff A, Malerczyk C. Potency requirements of rabies vaccines administered intradermally using the thai red cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine. Vaccine. 2005; 23:3902-7.10.1016/j.vaccine.2005.03.007Open DOISearch in Google Scholar

10. Strady A, Lang J, Lienard M, Blondeau C, Jaussaud R, Plotkin SA. Antibody persistence following preexposure regimens of cell culture rabies vaccines: 10- year follow-up and proposal for a new booster policy. JID. 1998; 177:1290-5.10.1086/515267Open DOISearch in Google Scholar

11. Ajjan N, Pilet Ch. Comparative study of the safety and protective value in pre-exposure use of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on vero cells. Vaccine. 1989; 7:125-8.10.1016/0264-410X(89)90050-9Open DOISearch in Google Scholar

12. Fishbein DR, Pacer RE, Holmes DF, Ley AB, Yager P, Tong TC. Rabies post-exposure prophylaxis with human diploid cell rabies vaccine: a dose-response study. J Infect Dis. 1987; 156:50-5.10.1093/infdis/156.1.50Open DOISearch in Google Scholar

13. Madhusudana SN, Premanand N. Response to purified chick embryo cell rabies vaccine administered intradermally for post-exposure prophylaxis. The National Medical Journal of India. 1997; 10:115-6.Search in Google Scholar

14. Ubol S, Phanuphak P. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment. Clin Exp Immunol. 1986; 63:491-7.Search in Google Scholar

15. Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero cell rabies vaccine. Bulletin of the World Health Organization. 2000; 78:693-8.Search in Google Scholar

16. Madhusudana SN, Prem Anand N, Shamsundar R. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for postexposure prophylaxis of rabies. The National Medical Journal of India. 2001; 14:145-7.Search in Google Scholar

17. Madhusudana SN, Saha SM, Sood M, Saxena SN. Multisite intradermal vaccination using tissue culture vaccine as an economical prophylactic regimen against rabies. Indian J Med Res. 1987:1-4.Search in Google Scholar

18. Madhusudana SN. Pre-exposure immunization with cell culture rabies vaccines by intradermal route: A longitudinal study of the immune responses and effect of yearly booster dose. Journal of Basic & applied Biomedicine. 1997; 5:19-23.Search in Google Scholar

19. Madhusudana SN, Prem Anand N, Shamsundar R. Economical multi-site intradermal regimen with purified chick embryo cell vaccine prevents rabies in people bitten by confirmed rabid animals. International journal of Infectious Diseases. 2002; 6:15-9.10.1016/S1201-9712(02)90113-XOpen DOISearch in Google Scholar

20. Sehgal S, Bhardwaj M, Bhatia R. Clinical evaluation of purified chick embryo cell anti rabies vaccine in healthy volunteers. J. Com. Dis. 1988; 20:247-52.Search in Google Scholar

21. Bernard KW, Mallonee J, Wright JC, Reid FL, Makintubee S, Parker RA. Preexposure immunization with intradermal human diploid cell rabies vaccine. JAMA. 1987; 1:437-45.10.1001/jama.1987.03390080049028Search in Google Scholar

22. Chutivongse S, Wilde H, Supich C, Baer GM, Fishbein DB. Post exposure prophylaxis for rabies with antiserum and intradermal vaccination. The Lancet. 1990; 335:896-8.10.1016/0140-6736(90)90488-QOpen DOISearch in Google Scholar

23. Sudarshan MK, Bhardwaj S, Mahendra BJ, Sharma H, Sanjay TV, Ashwath Narayana DH et al. An Immunnogenicity, safety and post marketing surveillance of a novel adsorbed human diploid cell rabies vaccine in Indian subjects. Human Vaccines. 2008; 4:275-9.10.4161/hv.4.4.558818682695Open DOISearch in Google Scholar

24. Sudarshan MK, Madhusudhana SN, Mahendra BJ. Post exposure prophylaxis with purified verocell rabies vaccine during pregnancy-safety and immunogenicity. J.Commun. Dis. 1999; 31:229-36.Search in Google Scholar

25. Sudarshan MK, Mahendra BJ, Madhusudhana SN, Ashwath Narayana DH. Administration of purified verocell rabies vaccine during pregnancy: Results of a controlled clinical trial. J. of Obst. & Gyn. of India. 2002; 52:48-52.Search in Google Scholar

26. Madhusudana SN, Sanjay TV, Mahendra BJ, Sudarshan MK, Ashwath Narayana DH, Anandgiri et al. Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCEC) and purified vero cell rabies vaccine (PVRV) using the thai red cross intradermal regimen at a dose of 0.1ml. Human Vaccines. 2006; 2:200-4.10.4161/hv.2.5.319717035734Open DOISearch in Google Scholar

27. Sudarshan MK, Mahendra BJ, Madhusudhana SN, Ashwath Narayana DH, Jayakumary M, Gangaboraiah. Post exposure rabies prophylaxis with purified verocell rabies vaccine: A study of immune response in pregnant women and their matched controls. Indian Journal of Public Health. 1999; 43:76-8.Search in Google Scholar

28. Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified thai red cross regimen. International Journal of Infectious Diseases. 2004; 8:175-9.10.1016/j.ijid.2003.07.00115109593Open DOISearch in Google Scholar

29. A report on “A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV), administered intradermally using updated Thai Red Cross regimen in animal bite cases. 2007, Novartis Vaccines, India.Search in Google Scholar

30. A report on “A comparative, multi center Phase III, randomized (1:1) double blind study to evaluate the safety and immunogenicity of PVRV (Indirab vs. reference vaccine) administered intradermally using simulated updated Thai Red cross regimen in healthy volunteers. 2009, Bharath Biotech International Ltd, Hyderabad, India.Search in Google Scholar

31. A report on “A comparative phase III, randomized (1:1) single blind study to evaluate the safety and immunogenicity of rabies vaccines (Indirab vs reference vaccine) reconstituted with 1 mL diluent each, administered intradermally using simulated post exposure updated Thai Red Cross regimen in healthy volunteers”. 2009, Bharath Biotech International Ltd, Hyderabad, India.Search in Google Scholar

32. Mahendra BJ, Madhusudhana SN, Ashwath Narayana DH, Sampath G, Datta SS, Gangaboraiah et al. A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine manufactured in India and Switzerland: A randomized simulated post-exposure study in healthy volunteers. Vaccine. 2007; 25:8405-9.10.1016/j.vaccine.2007.10.00217981377Open DOISearch in Google Scholar

33. Ashwath Narayana DH, Madhusudhana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HS et al. A comparative study on the safety and immunogenicity of purified duck embryo vaccine with purified chick embryo cell vaccine and purified verocell rabies vaccine. Vaccine. 2010; 28:148-51.10.1016/j.vaccine.2009.09.09019818720Open DOISearch in Google Scholar

34. Sampath G, Madhusudhana SN, Sudarshan MK, Ashwath Narayana DH, Mahendra BJ, Ullas TP et al. Immunogenicity and safety study of Indirab: A vero cell based chromatographically purified human rabies vaccine. Vaccine. 2010; 28:4086-90.10.1016/j.vaccine.2010.03.06420403351Open DOISearch in Google Scholar

35. Mahendra BJ, Madhusudana SN, Sampath G, Datta SS, Ashwath Narayana DH, Venkatesh GM et al. Immunogenicity, safety and tolerance of a purified duck embryo vaccine (PDEV, VAXIRAB) for rabies post-exposure prophylaxis: Results of a multicentric study in India. Human vaccines. 2010; 6:721-4.10.4161/hv.6.9.1221620861692Open DOISearch in Google Scholar

36. In a conversation with H. Wilde, MD and T. Hemachudha, MD, March 2011. Search in Google Scholar